Newsletter | June 30, 2025

06.30.25 -- Refresh Your CTA Strategy With Cybersecurity And EHRs In Mind, Part One

CLINICAL SITES

Refresh Your CTA Strategy With Cybersecurity And EHRs In Mind

Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part one of this two-part series explores cybersecurity and EHR standards. 

Building A Gold Standard Trial Experience In Japan

Learn how a Japanese sponsor elevated their trial experience, achieved >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards.

PATIENT CENTRICITY

Single Peptides: How Longhorn's Developing Its Universal Flu Shot

CEO Jeff Fischer discusses Longhorn's long-acting universal flu vaccine, from its suitability for testing in pigs to overcoming vaccine hesitancy.

How Patients Process Medical Information

Health literacy shapes clinical trial decisions. Clear, accessible communication empowers patients to understand risks and options, fostering informed consent, engagement, and equitable trial participation.

What Treatment Options Do You Have For Me?

Examine the complexities surrounding patient access to treatment options, particularly in the context of clinical trials.

A Patient's Life-Changing Experience With Diabetes Research

Discover the inspiring journey of one man who battled diabetes and experienced a transformative shift in his life through a patient-focused clinical trial at the Elligo Clinical Research Center.

PATIENT RECRUITMENT

BioMarin Generates Patient Experience Data With Early And Often Engagement

BioMarin Pharmaceutical's Ebony Dashiell-Aje, Ph.D., discusses how early and often patient engagement facilitates rich patient experience data generation.

Pioneering Clinical Research For Native American Communities

Lynn Bartholow is transforming clinical research for Native American populations. See her journey into clinical research and efforts to build trust and foster participation and community engagement.

The Transformative Impact Of EDC Systems In 2025

The shift towards decentralized and hybrid trials underscores the significance of EDC in expanding geographic reach, fostering diversity in participant populations, and reduce participant burden.

Unlocking Recruitment Potential In Trial-Naïve Sites

Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.

Efficient Patient Recruitment Services For Clinical Trials

When you can’t find the right patients at the right time, you may experience market delays and financial losses. Secure the patients you need, complete your trial on time, and improve your study outcomes.

SURVEY

Have you outsourced in clinical trials?

Tell Clinical Leader how we can better support you in finding the right partners. 

 

Share your thoughts here.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical SitesPatient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: